These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1728313)

  • 1. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
    Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.
    Hershko C; Konijn AM; Nick HP; Breuer W; Cabantchik ZI; Link G
    Blood; 2001 Feb; 97(4):1115-22. PubMed ID: 11159545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.
    Rivkin G; Link G; Simhon E; Cyjon RL; Klein JY; Hershko C
    Blood; 1997 Nov; 90(10):4180-7. PubMed ID: 9354689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    J Lab Clin Med; 2001 Aug; 138(2):130-8. PubMed ID: 11477380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
    Hershko C; Link G; Pinson A; Peter HH; Dobbin P; Hider RC
    Blood; 1991 May; 77(9):2049-53. PubMed ID: 2018841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C
    Blood; 1978 Mar; 51(3):415-23. PubMed ID: 623907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
    Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
    Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.
    Bergeron RJ; Streiff RR; Wiegand J; Luchetta G; Creary EA; Peter HH
    Blood; 1992 Apr; 79(7):1882-90. PubMed ID: 1558978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
    Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
    Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.
    Porter JB; Gyparaki M; Burke LC; Huehns ER; Sarpong P; Saez V; Hider RC
    Blood; 1988 Nov; 72(5):1497-503. PubMed ID: 3179437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R; Miller J; Crosby W
    Blood; 1981 May; 57(5):866-72. PubMed ID: 7214016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S
    J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
    Hershko C; Grady RW; Link G
    Br J Haematol; 1982 Jun; 51(2):251-60. PubMed ID: 7082583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH; Licéaga J; Arthur HM; Kontoghiorghes GJ
    Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G; Pinson A; Hershko C
    Blood; 1994 May; 83(9):2692-7. PubMed ID: 8167347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG; Randell EW; Olivieri NF; Templeton DM
    Biochim Biophys Acta; 1995 Apr; 1243(3):373-80. PubMed ID: 7727512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site.
    Porter JB; Abeysinghe RD; Hoyes KP; Barra C; Huehns ER; Brooks PN; Blackwell MP; Araneta M; Brittenham G; Singh S
    Br J Haematol; 1993 Sep; 85(1):159-68. PubMed ID: 8251385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
    Eybl V; Caisová D; Koutenský J; Kontoghiorghes GJ
    Arch Toxicol Suppl; 1991; 14():185-7. PubMed ID: 1805729
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
    Hershko C; Grady RW; Link G
    Haematologia (Budap); 1984; 17(1):25-33. PubMed ID: 6427069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.